> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# RenovoRx Infusion Catheter Expanded Use
- URL: https://www.fdaweb.com/renovorx-infusion-catheter-expanded-use/
- Published: 2017-03-30T12:00:00.000Z
- Updated: 2026-09-14T22:14:52.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5138341

FDA has cleared a RenovoRx 510(k) for its RenovoCath adjustable dual-balloon infusion catheter to include “delivery of chemotherapeutics.” The device isolates segments of the peripheral vasculature, allowing physicians to deliver therapeutic agents in a more targeted approach. “Studies show that the targeted delivery of chemotherapy may allow for higher concentrations of chemotherapy to reach the desired target, while potentially reducing overall side-effects typically associated with systemically delivered chemotherapy,” the company says.

  
The device’s dual balloons can be inflated independently and, unlike other catheters, the distance between the two balloons can be adjusted to isolate the desired treatment target, RenovoRx says. “This adjustable length may allow for truly targeted therapy, while reducing washout of the therapy and potential systemic side effects,” it says.